Specialty Development News Today

The border delimitation between azerbaijan and armenia and the signing of a peace treaty between them. Vladimir putin also noted that it is necessary to ensure the rights and safety of armenians living. The kremlin believes that there are all the prerequisites for the conclusion of a peace treaty between yerevan and baku, but it is premature to talk about the timing of the conclusion of the agreement , the president ial press secretary said. Dmitry peskov in his opinion. A period of sustainable ...

Are proof of this. During a time of war, we ask our troops to give their best even to the point of sacrificing their own lives. When compared against that how much of a sacrifice is it for a president to engage in a possibly contentious debate. How much of a sacrifice is it for a member of congress to debate and vote about whether military action is a good idea . While congressional members face the political costs of debate on military action, our Service Members bear the human costs of those d...

/PRNewswire/ -- Life Time Buckhead at Phipps Plaza opens today as the newest anchor in the redeveloped Phipps Plaza in Atlanta. The 127,000-square-foot...

127,000-square-foot project features five-story athletic country club with rooftop beach club and Life Time Work coworking space CHANHASSEN, Minn....

SAN FRANCISCO and BOSTON, April 04, 2022 (GLOBE NEWSWIRE) -- 5AM Venture Management, LLC (“5AM”) is pleased to announce the closing of two new funds,...

/PRNewswire/ -- Lakewood-Amedex Inc., a privately held, clinical stage pharmaceutical discovery and development company advancing a broad portfolio of...

/PRNewswire/ -- Lakewood-Amedex Inc., a privately held, clinical stage pharmaceutical discovery and development company advancing a broad portfolio of...

Investegate announcements from NuCana plc, NuCana Appoints Elliott M. Levy, M.D. to its Board of Directors

Published: May 21, 2021 By Alex Keown Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.  AavantiBio – Jessie Hanrahan was named chief regulatory officer of AavantiBio. Hanrahan will oversee global regulatory affairs for AavantiBio’s diversified pipeline of gene therapy programs targeting rare diseases with significant unmet medical needs. Most recently, she was Vice President of Regulatory Science at bluebird bio, Inc. Pr...

Share this article Share this article CAMBRIDGE, Mass., May 20, 2021 /PRNewswire/ -- Omega Therapeutics, Inc. ("Omega"), a development-stage biotechnology company leveraging its OMEGA Epigenomic Programming™ platform to harness the power of epigenetics and pioneer novel DNA-sequence-based targets and develop a new class of mRNA-encoded programmable epigenetic medicines, today announced the appointment of Elliott M. Levy, M.D., to its Board of Directors. Dr. Levy is an industry veteran with ov...